Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

BACKGROUND: The long-term antibody response to measles vaccine (MV) administered at age 6 months with or without subsequent doses is not well documented. METHODS: Measles serum antibody responses were evaluated after a supplemental dose of measles vaccine (sMV) administered at a median age of 20 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowlkes, Ashley L., Witte, Desiree, Beeler, Judy, Audet, Susette A., Broadhead, Robin, Bellini, William J., Cutts, Felicity, Helfand, Rita F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737013/
https://www.ncbi.nlm.nih.gov/pubmed/26873052
http://dx.doi.org/10.1016/j.vaccine.2016.01.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737013/
https://www.ncbi.nlm.nih.gov/pubmed/26873052
http://dx.doi.org/10.1016/j.vaccine.2016.01.055

Ejemplares similares